Prediction of Stroke Outcome in Mice Based on Noninvasive MRI and Behavioral Testing.

"data are openly accessible on zenodo ( https://doi org/10 5281/zenodo 6534690 )."

"the prediction models were uploaded and are available at github com/major-s/mouse-mcao-outcome-predictor."

"Disclosures Dr Endres reports grants from Bayer and fees paid to the Charité from Abbot, Amgen, AstraZeneca, Bayer Healthcare, Boehringer Ingelheim, BMS, Daiichi Sankyo, Sanofi, Novartis, Pfizer, all outside the submitted work. Dr Wenger holds patents on neuromodulation technologies that are unrelated to this work. All remaining authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or nonfinancial interest in the subject matter or materials discussed in this article. No funding was received to assist with the preparation of this article."

"Sources of Funding Funding was provided by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) to Drs Hoffmann and Harms (project number, 417284923), to Dr Boehm-Sturm (project number, 428869206), to Drs Wenger, Endres, and Harms (project number 424778381–TRR 295) and NeuroCure (EXC−2049 to —390688087) and the German Federal Ministry of Education and Research (BMBF, Center for Stroke Research Berlin 01EO1301) to Drs Dirnagl, Boehm-Sturm, and Harms, and to Dr Boehm-Sturm by the BMBF under the ERA-NET NEURON scheme (01EW1811). Dr Kuffner received funding from the DFG Graduate School 203. This work was supported by Charité3R| Replace–Reduce–Refine and partly by the Fondation Leducq to Drs Endres and Harms. Drs Knab and Eggers received a scholarship from the Berlin Institute of Health, Berlin. Dr Euskirchen, Wenger, and Hoffmann are participants in the Charité Clinical Scientist Program funded by the Charité – Universitätsmedizin Berlin and the Berlin Institute of Health and Dr Wenger is a Freigeist Fellow with support from the Volkswagen Foundation. In addition, this work was supported by DFG (Project number 73500270 and 413848220) and ERA-NET NEURON EBio2, with funds from BMBF 01EW2004 to Dr Dreier. Dr Endres received funding from DFG under Germany´s Excellence Strategy—EXC-2049—390688087, Collaborative Research Center ReTune TRR 295- 424778381, BMBF, DZNE, DZHK, EU, Corona Foundation, and Fondation Leducq. am received funding from DFG and Fondation Leducq."